Clobazam

Clobazam is 7-Chloro-1H-1,5-benzodiazepine-2,4(3H,5H)-dione in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group, whilst that attached to the other nitrogen is substituted by a phenyl group. It is used for the short-term management of acute anxiety and as an adjunct in the treatment of epilepsy in association with other antiepileptics. Among its listed roles, it functions as a anticonvulsant, an anxiolytic drug and a GABA modulator. It is a 1,4-benzodiazepinone and an organochlorine compound. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines, Neurotransmitter agents, Psychotropic agents, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as anti-epileptic drugs, antianxiety drugs, anticonvulsants and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Clorepin and Urbadan. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 2789.